Manufacturers think CMS bars them from helping Medicare patients afford their medicines. This is incorrect. There are solutions...
read full article ›Diversity is now rightly a corporate priority in America. Companies large and small know that improving their diversity and inclusion policies will improve their culture and workforce. And Pharma is no different. Pharmas want more diverse representation in management, their boards, and in clinical trials. Should a similar lens be applied to access and reimbursement challenges – and in particular to patient support programs?
read full article ›